Thrombin-activatable fibrinolysis inhibitor (TAFI): A novel predictor of angiographic coronary restenosis

Herbert K. Lau, Amit Segev, Robert A. Hegele, John D. Sparkes, Jerome M. Teitel, Robert J. Chisholm, Bradley H. Strauss*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

22 Scopus citations

Fingerprint

Dive into the research topics of 'Thrombin-activatable fibrinolysis inhibitor (TAFI): A novel predictor of angiographic coronary restenosis'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

Biochemistry, Genetics and Molecular Biology

Neuroscience